The cost-effectiveness of adding an ultrasound corticosteroid and local anaesthetic injection to advice and education for hip osteoarthritis
Authors' conclusion
Intra-articular corticosteroid injection plus BCT (BCT+US-T) for patients with hip OA results in lower costs and better outcomes, and is highly cost-effective, compared with BCT alone.
Study context
- Population
- People with hip osteoarthritis (OA)
- Comparison
- Best current treatment (BCT) plus a single US-guided intra-articular hip injection of 40 mg triamcinolone acetonide and 4 ml 1% lidocaine hydrochloride vs BCT alone
- Outcome
- Cost per QALY gained (NHS perspective)
- Follow-up
- 6 months
Methodological detailsUK National Health Service (NHS) perspective, 6-month time horizon
- UK NHS perspective
- 6-month time horizon
Main finding
As reported in the abstract
Difference in mean NHS costs
-£161.6
95% CI -£583.95, £54.18
BCT+US-T
Difference in mean quality-adjusted life years (QALYs)
0.0487 QALYs
95% CI 0.0091–0.0886
BCT+US-T
Further findings
Drivers of differences in total costs
- Visits to NHS consultants, private physiotherapists and chiropractors, and hip surgery were more common with BCT alone than BCT+US-T
Original publication
The cost-effectiveness of adding an ultrasound corticosteroid and local anaesthetic injection to advice and education for hip osteoarthritis. Rheumatology (Oxford). Published 12 December 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →